Related Experiment Videos
Ongoing vascular laboratory surveillance is essential to maximize long-term in situ saphenous vein bypass patency
C A Erickson1, J B Towne, G R Seabrook
1Department of Vascular Surgery, Medical College of Wisconsin, Milwaukee 53226, USA.
Insights
Ongoing graft surveillance is crucial for maintaining long-term patency in lower limb bypasses. Regular monitoring detects abnormalities, allowing timely interventions to preserve graft function and prevent failure.
Area of Science:
- Vascular Surgery
- Graft Patency
- Lower Limb Bypass
Background:
- Lower limb in situ saphenous vein bypasses are a common surgical procedure.
- Maintaining long-term graft patency is essential for successful outcomes.
Purpose of the Study:
- To evaluate the effectiveness of continuous graft surveillance in maximizing the long-term patency of lower limb in situ saphenous vein bypasses.
Main Methods:
- A prospective study of 556 autogenous grafts in 499 patients from 1981 to 1994.
- Regular surveillance evaluations were performed at increasing intervals post-operation.
- Abnormalities were identified and intervention strategies were employed.
Main Results:
- 450 abnormalities were detected in 236 grafts, with a median detection interval of 12 months.
- Significant abnormalities continued to develop more than 2 years post-operation.
- 11% of grafts without early abnormalities eventually failed, highlighting the need for long-term monitoring.
Conclusions:
- Lesions compromising graft patency can develop years after bypass surgery.
- Perpetual surveillance is necessary to ensure optimal graft patency rates.
- Timely interventions based on surveillance findings are key to long-term success.
Purpose:
The purpose of this study was to assess the contribution of ongoing graft surveillance to maximize long-term patency of lower limb in situ saphenous vein bypasses.
Methods:
From January 1981 to October 1994, 556 autogenous grafts were constructed in 499 patients. The distal anastomosis was at the popliteal level in 207 (37%) and the tibial level in 349 (63%). All patients were enrolled in a prospective surveillance protocol to identify lesions that compromise graft patency and were evaluated at 1 day, 1 week, 6 weeks, and 3 months. Surveillance studies were then obtained every 3 months for the first 2 postoperative years and every 6 months thereafter.
Results:
Four-hundred-fifty abnormalities were detected in 236 grafts. The median interval from the initial procedure to detection of an abnormality was 12 months (range 0 to 113 months) and varied with the location of the defect. Later in the life of the graft, progression of atherosclerotic disease manifested as inflow obstruction at a median of 15 months, and outflow disease threatened the graft at a median of 29 months (r = 0.0003). Of the 450 surveillance abnormalities, 294 (65%) occurred within the first 2 years after operation, and 156 (35%) developed more than 2 years after operation. Of the 236 grafts that developed surveillance abnormalities, 50 (21%) developed the initial defect more than 2 years after the initial bypass procedure. Eleven percent of grafts remaining free of abnormality after 2 years went on to fail. Sixty-seven interventions were performed on 62 extremities after 24 months, with 30 involving previously unrevised grafts.
Conclusions:
Because lesions amenable to revision continue to develop years after vein bypass construction, perpetual surveillance is required to ensure optimal rates of graft patency.